Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial
PaperCitations, authors & open-access status
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 144 citations, 2016 year and green oa status.
144
Citations
2016
Year
green
OA Status